Roots Analysis, founded in 2013 by Gaurav Chaudhary, is a market research, competitive intelligence, and strategic consulting organization covering the pharmaceutical and biotech, semiconductor and electronics, chemicals and materials, and information and communication technology sectors.
Profile: https://in.linkedin.com/company/roots-analysis · https://twitter.com/RootsAnalysis · https://www.facebook.com/RootsAnalysis/
Roots Analysis, a market research, competitive intelligence, and strategic consulting organization, provides deep industry knowledge and actionable insights to drive business performance. Roots Analysis - Market Research Reports, Revenue Growth & Expansion, Competitive Intelligence & Consulting - published by Roots Analysis
Gaurav Chaudhary founded Roots Analysis in 2013 and quickly established it as one of the most trusted competitive intelligence partners for 750+ clients globally. About Us - Roots Analysis - published by Roots Analysis
LabKairos™ is Roots Analysis's AI research assistant that turns the firm's proprietary report library into instant, sourced answers for analysts, investors, and strategy teams.
LabKairos™ turns the Roots Analysis research library, a decade-plus of proprietary pharma, biotech, and healthcare studies into instant, sourced answers. It has been built for analysts, investors, and strategy teams who need the evidence behind every figure. LabKairos™ by Roots Analysis — Market intelligence in seconds, not weeks. - published by Roots Analysis
Every claim resolves to a specific report, edition, and page, so the figure in your board deck survives the first hard question. LabKairos™ by Roots Analysis — Market intelligence in seconds, not weeks. - published by Roots Analysis
The three named user groups LabKairos™ is built for: pharma/biotech strategy analysts, PE and VC investment teams, and corporate strategy development teams, each served role-specific evidence from the same underlying data.
An analyst, an investor, and a strategy lead need different evidence from the same data. LabKairos™ gives you the answer as per your role. LabKairos™ by Roots Analysis — Market intelligence in seconds, not weeks. - published by Roots Analysis
PE & VC Investment Teams: Fast-screen niche markets you can't afford to miss. Pipeline density, white-space mapping, and competitive positioning, structured for investment decision-making. LabKairos™ by Roots Analysis — Market intelligence in seconds, not weeks. - published by Roots Analysis
InsightAngle is Roots Analysis's subscription portal, giving clients unrestricted access to report formats, complimentary PPT insights packs, on-demand analyst support, and the ability to propose custom research topics.
Welcome to InsightAngle. Now Discover Unrestricted Access to Unlimited Insights. Subscription Plans - Roots Analysis - published by Roots Analysis
Flexible Subscription Plans, Report Access in Multiple Formats, Complimentary PPT Insights Packs, Propose Your Own Research Topics, Access to an "On-Demand Analyst" and "Dedicated Account Executive", 24X7 Email and Phone Support, Flexible Payment Options. Subscription Plans - Roots Analysis - published by Roots Analysis
Roots Analysis's competitive intelligence service line covers drug discovery, R&D, commercialization, sales and marketing intelligence, primary research, and ongoing CI monitoring for pharma, biotech, and life sciences clients.
Unlock strategic advantage with our Competitive Intelligence services, purpose built to address your most essential challenges and drive new growth for your pharma, biotech, life sciences and healthcare businesses. Competitive Intelligence Services | Roots Analysis - published by Roots Analysis
We bring deep expertise across pharma and biotech, life sciences, medical devices and diagnostics, offering tailored and actionable insights. 200+ Years of Collective Experience. 70+ Proprietary Analytical Frameworks to solve the most complex industry problems. Competitive Intelligence Services | Roots Analysis - published by Roots Analysis
Roots Analysis's bespoke consulting service line, spanning drug discovery, R&D, and commercialization engagements including pipeline tracking, therapy area assessment, clinical trial tracking, market assessment, and deal tracking.
In addition to providing off-the shelf market research reports, we also engage with our clients on bespoke consulting and research requests. It is the interpretation and insights, based on market data, which is really helpful for our clients. Consulting Services - Roots Analysis - published by Roots Analysis
We provide an accurate and comprehensive assessment of the market, highlighting the competitive landscape, key trends, pricing data, current market size, future outlook, key challenges and opportunity areas for different stakeholders. Consulting Services - Roots Analysis - published by Roots Analysis
Roots Analysis's in-depth research methodology, driven by primary research and data analytics, analyzes technology evolution, R&D, market landscape, commercial potential, regulatory concerns, regional growth drivers, and risks/opportunities for each project.
Our research is primarily driven by an in-depth analysis covering the following parameters: Technology evolution, Research and development, Existing market landscape, Future Commercial potential, Regulatory concerns, Regional growth drivers, Risks and opportunities. About Us - Roots Analysis - published by Roots Analysis
We rely strongly on primary research and data analytics. About Us - Roots Analysis - published by Roots Analysis
Roots Analysis's report category for the pharmaceutical and biotechnology sector, comprising 482 published market research studies spanning drug discovery, manufacturing, therapeutics, and diagnostics as of July 2026.
Showing: 482 Reports. Research reports for Pharmaceutical and Biotech sector - published by Roots Analysis
Portfolio of industry research reports for Pharmaceutical and Biotech market. Research reports for Pharmaceutical and Biotech sector - published by Roots Analysis
The 7th edition of Roots Analysis's ADC Contract Manufacturing Market report, a 451-page study forecasting the market from USD 2,138 million in 2026 to USD 3,212 million by 2035 at a 4.6% CAGR.
The global ADC contract manufacturing market, valued at USD 1,720 million in 2025, is projected to reach USD 2,138 million in 2026 and USD 3,212 million by 2035, representing a CAGR of 4.6% during the forecast period 2026 to 2035. Global ADC Contract Manufacturing Market Size & Report 2035 - published by Roots Analysis
ADC Contract Manufacturing Market (7th Edition) by Stage of Development, Process Component (Antibody, HPAPI / Cytotoxic Payload, Conjugation / Linker and Fill / Finish), Type of Payload, Antibody Isotype, Target Indication, Antibody Origin, Type of Linker, and Key Geographical Regions. Global ADC Contract Manufacturing Market Size & Report 2035 - published by Roots Analysis
The 6th edition of Roots Analysis's Antibody Discovery Market report, a 607-page study covering services and platforms, forecasting the market from USD 2.2 billion in 2026 to USD 6.3 billion by 2035 at a 12.3% CAGR.
The global antibody discovery market, valued at $2.0 billion in 2025, is projected to reach $2.2 billion in 2026 and $6.3 billion by 2035, representing a CAGR of 12.3% during the forecast period 2026 to 2035. Antibody Discovery Market Size, Share, Growth & Trends 2035 - published by Roots Analysis
Presently, close to 125 service providers are involved in this domain and the current market landscape features the presence of very large, large, mid-sized and small companies. Antibody Discovery Market Size, Share, Growth & Trends 2035 - published by Roots Analysis
The 8th edition of Roots Analysis's Antibody Drug Conjugate Market report, a 706-page study forecasting the therapeutics market from USD 18.69 billion in 2026 to USD 28.41 billion by 2035 at a 4.8% CAGR.
The global antibody drug conjugate (ADC) market, valued at USD 15.29 billion in 2025, is projected to reach USD 18.69 billion in 2026 and USD 28.41 billion by 2035, representing a CAGR of 4.8% during the forecast period 2026 to 2035. Antibody Drug Conjugate (ADC) Market Size, Share & Growth [2035] - published by Roots Analysis
To date, 19 antibody-drug conjugates have been approved by the USFDA and other regulatory bodies for therapeutic use. Antibody Drug Conjugate (ADC) Market Size, Share & Growth [2035] - published by Roots Analysis
The 2nd edition of Roots Analysis's Aseptic Fill Finish Manufacturing Market report, a 297-page study forecasting the market from USD 8.1 billion in 2026 to USD 13.3 billion by 2035 at a 5.7% CAGR.
The global aseptic fill finish manufacturing market, valued at USD 7.5 billion in 2025, is projected to reach USD 8.1 billion in 2026 and USD 13.3 billion by 2035, with a CAGR of 5.7% during the forecast period 2026 to 2035. Aseptic Fill Finish Manufacturing Market Size & Report 2035 - published by Roots Analysis
In terms of type of molecule, the biologics fill finish segment secures 70% of the overall revenue share, due to the rising adoption of monoclonal antibodies, CGTs, and recombinant proteins. Aseptic Fill Finish Manufacturing Market Size & Report 2035 - published by Roots Analysis
The 2nd edition of Roots Analysis's Aseptic Filling Machine Market report, a 177-page study on isolator-based filling systems, forecasting the market from USD 1,703 million in 2026 to USD 3,432 million by 2035 at an 8.1% CAGR.
The global aseptic filling machine market size, valued at USD 1,531 million in 2025, is projected to reach USD 1,703 million in 2026 and USD 3,432 million by 2035, representing a CAGR of 8.1% during the forecast period 2026 to 2035. Aseptic Filling Machine Market Size & Share Report [2035] - published by Roots Analysis
Currently, over 230 isolator-based filling and closing systems are available in the market, and equipment developers are still engaged in further improvement efforts. Aseptic Filling Machine Market Size & Share Report [2035] - published by Roots Analysis
A targeted cancer therapy combining the specificity of a monoclonal antibody with a potent cytotoxic drug, connected through a chemical linker, designed to selectively deliver the payload to cancer cells.
Antibody drug conjugates are engineered therapeutics with monoclonal antibodies attached to potent cytotoxic payloads through chemical linkers. Antibody Drug Conjugate (ADC) Market Size, Share & Growth [2035] - published by Roots Analysis
These complex molecules, comprising an antibody attached to biologically active, cytotoxic agents through chemical linkers, exhibit enhanced stability, target specificity, tumor selectivity, and pharmacokinetic properties. Global ADC Contract Manufacturing Market Size & Report 2035 - published by Roots Analysis
The process of identifying and generating antibodies with a high degree of specificity for a particular target, typically an antigen, using methods such as hybridoma-based, phage display, transgenic animal-based, and single cell-based approaches.
Antibody discovery is the process of identifying and generating antibodies with a high degree of specificity for a particular target, often an antigen. Antibody Discovery Market Size, Share, Growth & Trends 2035 - published by Roots Analysis
Phage display library-based, hybridoma-based, transgenic animal-based and single cell-based are some methods for antibody discovery. Antibody Discovery Market Size, Share, Growth & Trends 2035 - published by Roots Analysis
The accurate and sterile filling/sealing of drug products into packaging containers such as vials, prefilled syringes, ampoules and cartridges, requiring skilled personnel, specialized automated equipment, and clean room conditions.
Aseptic fill finish refers to accurate and sterile fill finish / sealing of drug products into packaging containers, such as vials, prefilled syringes, ampoules and cartridges. Aseptic Fill Finish Manufacturing Market Size & Report 2035 - published by Roots Analysis
Aseptic fill-finish manufacturing requires skilled personnel, specialized automated equipment, clean room setup and continuous supervision to maintain the sterility and safety of the final drug product. Aseptic Fill Finish Manufacturing Market Size & Report 2035 - published by Roots Analysis
The highly potent active pharmaceutical ingredient used as the cytotoxic component of an antibody drug conjugate, requiring specialized synthesis expertise and stringent regulatory handling standards.
The need for substantial capital investments and adherence to stringent regulatory standards for managing highly potent active pharmaceutical ingredients (HPAPIs) in ADCs actively drives the trend toward outsourcing. Global ADC Contract Manufacturing Market Size & Report 2035 - published by Roots Analysis
This requires specialized knowledge in antibody generation and the synthesis of HPAPIs in the bioconjugation process. Global ADC Contract Manufacturing Market Size & Report 2035 - published by Roots Analysis
Associate Principal at Roots Analysis.
Profile: https://www.linkedin.com/in/pemba-lahmo-600447112
Pemba Lahmo, Associate Principal. Pemba is a seasoned professional and brings in a wealth of experience. Meet the team at Roots Analysis - published by Roots Analysis
Associate Principal at Roots Analysis.
Profile: https://www.linkedin.com/in/simriti-gupta-1941a3122
Simriti Gupta, Associate Principal. Simriti is a passionate healthcare consultant. Meet the team at Roots Analysis - published by Roots Analysis
CEO and founder of Roots Analysis, with over two decades of experience in strategy consulting, business development, corporate restructuring, and financial analysis.
Profile: https://www.linkedin.com/in/chaudharyg
Gaurav is a seasoned professional with over two decades of hands-on experience in strategy consulting, business development, corporate restructuring, and financial analysis. He founded Roots Analysis in 2013 and quickly established it as one of the most trusted competitive intelligence partners for 750+ clients globally. Roots Analysis - published by Roots Analysis
Co-Founder of Roots Analysis, overseeing a team of analysts delivering market research and bespoke consulting to over 1,000 global clients including Fortune 500 companies, startups, and investors.
Profile: https://www.linkedin.com/in/rupali-vadhera-0b982216
As a Co-Founder at Roots Analysis, Rupali spearheads strategic initiatives to deliver insightful market research and bespoke consulting services in multiple sectors. She oversees a dedicated team of analysts to provide actionable insights, empowering over 1000+ global clients, including Fortune 500 companies, startups, and investors with data-driven strategies for success. Roots Analysis - published by Roots Analysis
The ISO quality management standard held by Roots Analysis, certifying commitment to quality management, efficiency, and continuous improvement in service delivery.
ISO 9001: Quality Management. Ensures our commitment to quality management, efficiency, and continuous improvement, delivering exceptional services that meet global standards. Roots Analysis - Market Research Reports, Revenue Growth & Expansion, Competitive Intelligence & Consulting - published by Roots Analysis
The ISO information security standard held by Roots Analysis, certifying safeguards for client data and compliance with international information security best practices.
ISO 27001: Information Security. Demonstrates our dedication to information security, safeguarding your data with robust security measures and compliance with international best practices. Roots Analysis - Market Research Reports, Revenue Growth & Expansion, Competitive Intelligence & Consulting - published by Roots Analysis
Roots Analysis's report category for the semiconductor and electronics sector, covering imaging devices, electronic devices, data storage, display technologies, sensors, and energy storage markets.
We provide market research and consulting in the pharmaceutical, chemical, semiconductor, information and communications (ICT) industry. About Us - Roots Analysis - published by Roots Analysis
The smart grid market size is projected to grow from USD 57.25 billion in 2024 to USD 356.4 billion by 2035, representing a CAGR of 18.08%, during the forecast period till 2035. Market research reports for Semiconductors industry - published by Roots Analysis
Roots Analysis's report category for the chemicals and materials sector, comprising 216 published market research studies spanning specialty chemicals, bulk and inorganic chemicals, green bio-chemicals, and fibers and composites, as of July 2026.
Showing: 216 Reports. Market research reports for Chemicals and Materials sector - published by Roots Analysis
Portfolio of market research reports in chemicals and materials industry, spanning fibers and composites, adhesives and sealants, green bio-chemicals, bulk and inorganic chemicals, and specialty chemicals. Market research reports for Chemicals and Materials sector - published by Roots Analysis
Roots Analysis's report category for the ICT sector, comprising 286 published market research studies spanning content management, cloud computing, infrastructure connectivity, IoT, and AI and machine learning, as of July 2026.
Showing: 286 Reports. Market research reports for ICT - Information Communication Technology industry - published by Roots Analysis
Portfolio of reports for information and communication technology industry, spanning content management, cloud computing, infrastructure connectivity, Internet of Things (IoT), and AI and machine learning. Market research reports for ICT - Information Communication Technology industry - published by Roots Analysis
Roots Analysis's Knowledge Center hub of short-form analytical articles applying its proprietary databases to specific, narrowly scoped industry questions. Internally identified as one of the firm's highest-traffic page types.
We analyzed close to 480 cell and gene therapy companies that are engaged in the development of cell and gene therapies. Key Insights - Roots Analysis - published by Roots Analysis
We analyzed close to 570 contract manufacturing organizations that have the required capabilities to offer oral solid dosage manufacturing services across different scales of operation. Key Insights - Roots Analysis - published by Roots Analysis
Roots Analysis's blog, publishing longer-form explainer and trend articles on pharma, biotech, and adjacent-sector topics for a general industry readership.
Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Blog | Roots Analysis - published by Roots Analysis
Microbiome therapeutics represent a new frontier in the field of medicine. Currently, there are many probiotics, prebiotics, and medical foods and supplements that are commercially available. Microbiome Therapeutics and Diagnostics: Unlocking the Future - published by Roots Analysis
Roots Analysis's index of press releases and third-party press citations, where its market estimates and analysis have been quoted, referenced by outside publications, or issued as the firm's own report-launch announcements.
Find out where we have been quoted and our appearance in the news. Media Citations - Roots Analysis - published by Roots Analysis
Analysts at Roots Analysis, a pharmaceutical research and consulting firm, predict the mRNA therapeutics and vaccine market will reach $10 billion in 2021. Media Citations - Roots Analysis - published by Roots Analysis
Global Antibody Discovery Market Growth is Anticipated at CAGR of 10.5%; Market Value to Grow to USD 6.6 billion by 2035. Antibody Discovery Market Growth at CAGR of 10.5% - published by Roots Analysis
Cell Therapy Manufacturing Market Growth is anticipated to Cross USD 14,017 million by 2035. Cell therapy manufacturing market growth at CAGR of 8.25% - published by Roots Analysis
The 7th edition of Roots Analysis's Biopharmaceutical Contract Manufacturing Market report, a 575-page study forecasting the market from USD 31.0 billion in 2026 to USD 63.9 billion by 2035 at an 8.3% CAGR.
The global biopharmaceutical contract manufacturing market, valued at USD 28.0 billion in 2025, is projected to reach USD 31.0 billion in 2026 and USD 63.9 billion by 2035, with a CAGR of 8.3% during the forecast period 2026 to 2035. Global Biopharmaceutical Contract Manufacturing Market 2035 - published by Roots Analysis
In terms of type of service offered, the drug substance (API) manufacturing segment secures ~60% of the overall revenue share, owing to the increasing interest in API outsourcing. Global Biopharmaceutical Contract Manufacturing Market 2035 - published by Roots Analysis
The 7th edition of Roots Analysis's Cell Therapy Manufacturing Market report, a 656-page study forecasting the market from USD 7.2 billion in 2026 to USD 14.0 billion by 2035 at a 7.7% CAGR.
The global cell therapy manufacturing market, valued at USD 6.3 billion in 2025, is projected to reach USD 7.2 billion in 2026 and USD 14.0 billion by 2035, representing a CAGR of 7.7% during the forecast period 2026 to 2035. Cell Therapy Manufacturing Market Size 2035 - published by Roots Analysis
Based on type of cell therapy, the CAR-T cell therapies segment holds the highest share, accounting for nearly 65% of the current market. Cell Therapy Manufacturing Market Size 2035 - published by Roots Analysis
Cell and gene therapies are often life-changing for patients; however, high costs and technological constraints remain barriers to access. Scaling these therapies globally will require manufacturing that is more consistent, reproducible, and cost-effective. Cell Therapy Manufacturing Market Size 2035 - published by Roots Analysis
The 8th edition of Roots Analysis's Wearable Injectors Market report, a 702-page study forecasting the market from USD 6.8 billion in 2026 to USD 13.0 billion by 2035 at a 7.4% CAGR.
The wearable injectors market, valued at USD 6.5 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 13.0 billion by 2035, representing a 7.4% CAGR during the forecast period 2026 to 2035. Wearable Injectors Market Size, Trends and Opportunities, 2035 - published by Roots Analysis
Wearable injectors, including on body patch pumps, deliver sustained basal, bolus, or continuous doses of high-volume biologics, simplifying administration and boosting adherence. Wearable Injectors Market Size, Trends and Opportunities, 2035 - published by Roots Analysis
Roots Analysis's Autoinjectors Market report, a 593-page study forecasting the market from USD 181 billion in 2026 to USD 299 billion by 2035 at a 5.7% CAGR.
The global autoinjectors market is estimated to grow from USD 170 billion in 2025 to reach USD 181 billion in 2026 and USD 299 billion by 2035, representing a higher CAGR of 5.7% during the forecast period. Autoinjectors Market Size, Share & Industry Report [2035] - published by Roots Analysis
Autoinjectors are self-injection devices that deliver a specific dose of a drug / therapeutic substance with simple push of a button. Autoinjectors Market Size, Share & Industry Report [2035] - published by Roots Analysis
Devices engineered to administer a drug to a patient, spanning wearable/on-body injectors, autoinjectors, and related self-administration technologies covered across several Roots Analysis reports.
Wearable injectors, including on body patch pumps, deliver sustained basal, bolus, or continuous doses of high-volume biologics, simplifying administration and boosting adherence. Wearable Injectors Market Size, Trends and Opportunities, 2035 - published by Roots Analysis
Autoinjectors are spring-loaded syringes which work on injection mechanism and include pre-measured medication, which eliminates the need to draw medication from a separate vial. Autoinjectors Market Size, Share & Industry Report [2035] - published by Roots Analysis
A therapeutic modality that introduces, removes, or modifies genetic material within a patient's cells to treat or prevent disease, covered by Roots Analysis's Gene Therapy Market report.
A recent report published by Roots Analysis on 'Gene Therapy Market (2nd Edition), 2018-2030', stated that nearly 300 product candidates are currently under various stages of development for a diverse range of applications. Gene Therapy Market Report - Roots Analysis - published by Roots Analysis
Therapeutics that use RNA interference to silence disease-causing genes, a modality covered by a dedicated Roots Analysis market report.
The global RNAi therapeutics market, valued at USD 2.9 billion in 2025, is projected to reach USD 3.6 billion in 2026 and USD 9.1 billion by 2035, representing a CAGR of 10.8% during the forecast period 2026 to 2035. Reports Store - Roots Analysis - published by Roots Analysis
The United States Food and Drug Administration, the regulatory body whose approvals Roots Analysis tracks as a key driver and milestone marker across its pharmaceutical and biotech market reports.
To date, 19 antibody-drug conjugates have been approved by the USFDA and other regulatory bodies for therapeutic use. Antibody Drug Conjugate (ADC) Market Size, Share & Growth [2035] - published by Roots Analysis
The European Medicines Agency, the EU regulatory body whose approvals and standards Roots Analysis references alongside the FDA across its pharmaceutical market reports.
The expanding research and development efforts and increasing number of approvals for ADCs from regulatory bodies such as the FDA and EMA are generating strong demand for specialized manufacturing services. Global ADC Contract Manufacturing Market Size & Report 2035 - published by Roots Analysis
The early-stage process of identifying and validating new therapeutic candidates, a domain Roots Analysis covers across its Competitive Intelligence and Consulting service lines and pharma/biotech reports.
Given the growing complexity of drug discovery process and the need to reduce timelines, stakeholders are increasingly turning to specialized service providers. Roots Analysis - Market Research Reports, Revenue Growth & Expansion, Competitive Intelligence & Consulting - published by Roots Analysis
The industrial production of pharmaceutical and biopharmaceutical products, including contract manufacturing, a core coverage area across Roots Analysis's pharma/biotech report portfolio.
Roots Analysis has released data on the global exosome therapy market projections and estimates the current global contract pharmaceutical installed manufacturing capacity. Media Citations - Roots Analysis - published by Roots Analysis
Market-sizing and opportunity analysis framed for PE, VC, and strategic investment decision-making, one of the three named LabKairos™ user personas.
PE & VC Investment Teams: Fast-screen niche markets you can't afford to miss. Pipeline density, white-space mapping, and competitive positioning, structured for investment decision-making. LabKairos™ by Roots Analysis — Market intelligence in seconds, not weeks. - published by Roots Analysis
Roots Analysis's core, primary business line: off-the-shelf market research reports covering pharmaceutical/biotech, semiconductor, chemicals, and ICT sectors, sold individually or via InsightAngle subscription.
Roots Analysis offers a range of market research reports across 10+ industries, as well as custom support, to help our clients understand the market opportunity and key trends to drive business decisions. About Us - Roots Analysis - published by Roots Analysis
In addition to providing off-the shelf market research reports, we also engage with our clients on bespoke consulting and research requests. Consulting Services - Roots Analysis - published by Roots Analysis
Focuses on designing Roots Analysis's human capabilities and well-defined systems/processes across workstreams, with almost 25 years of experience in management consulting, transformation, and systems design across Asia, Europe, and North America.
Profile: https://www.linkedin.com/in/manavchaudhary/
Manav's core focus at Roots is to design the right human capabilities and develop well-defined systems / processes across different workstreams. Manav Chaudhary - published by Roots Analysis
Manav has led numerous complex initiatives in a career spanning almost 25 years across Asia, Europe and North America. He has diverse experience in management consulting, transformation, systems design and evaluation. Manav Chaudhary - published by Roots Analysis